<DOC>
	<DOCNO>NCT00636220</DOCNO>
	<brief_summary>This protocol intend test feasibility use HIV 1/2 STAT-PAK DPP HIV 1/2 test ( without DPP Handheld Reader ) detect HIV antibody oral fluid .</brief_summary>
	<brief_title>Evaluation DPP HIV 1/2 Test HIV 1/2 Stat Pak Test Using Oral Fluid</brief_title>
	<detailed_description>The objective study evaluate feasibility use fresh oral fluid specimen , know HIV-positive individual , test HIV-1 antibody use DPP HIV 1/2 HIV 1/2 STAT-PAK test . Two oral fluid collection device use compare ( MPC Chembio collection device ) result obtain oral fluid compare obtained whole blood plasma use pair sample participant . The comparison oral fluid , whole blood plasma make Chembio device ( HIV 1/2 STAT-PAK DPP HIV 1/2 ) .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Participants know HIV infection willing participate study sign inform consent ( assent ) , include study . Patients HAART treatment HIV include , information well date ( duration ) treatment obtain interview study participant ; medical record review necessary require . The study participant 's response record study staff Data Collection Form . Patients immunosuppressive condition HIV include available , limited &lt; 25 % total test population . Immunosuppression also assess interview study participant and/or verbal confirmation treat physician ; medical record/chart review require . Patients must willing undergo venipuncture donate one tube EDTA whole blood ( 10cc ) , provide three oral fluid sample . Patients consent , withdraw consent , investigator determines venipuncture gum swab may create health risk exclude study . Participants enrol HIV vaccine study exclude study . This ascertain interview study participant . Participants enrol study exclude repeat enrollment . Participants must introduce substance oral cavity ( gum , food , beverage , candy , lozenge , mouthwash , etc . ) 30 minute prior provide oral fluid sample . This ascertain interview study participant .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>HIV-1 Infections</keyword>
</DOC>